picotamide [orch, phsu]
progression [patf]
Peripheral [spco]
Vascular disease [dsyn]
Double-Blind Study [resa]
placebo-controlled [resa]
Patients [podg]
Peripheral vascular disease [dsyn]
Clinical course [tmco]
Complicated [ftcn]
cardiovascular events [fndg]
Several [qnco]
Circulation [phsf]
Methods [inpr]
Present [qnco]
Study [mnob]
investigated [ftcn]
Ability [orga]
picotamide [orch, phsu]
Substance [sbst]
arrested [dsyn]
Platelet [cell]
Thromboxane A2 [eico]
synthase [aapp, enzy]
Receptors, Thromboxane A2 [aapp, rcpt]
cardiovascular complications [patf]
Peripheral vascular disease [dsyn]
Patients [podg]
Study [mnob]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Run-in Period [tmco]
Patients [podg]
placebo [topp]
picotamide [orch, phsu]
mg% [qnco]
i d [topp]
months [tmco]
Minor [popg]
Events [evnt]
Intention [menp]
Patients [podg]
picotamide [orch, phsu]
suffered [mobd]
Events [evnt]
Minor [popg]
Events [evnt]
Take [hlca]
placebo [topp]
suffered [mobd]
4 5 [qnco]
Minor [popg]
Events [evnt]
Borderline [qlco]
Statistical [ocdi]
Group [idcn]
Sum [qnco]
Minor [popg]
Events [evnt]
Risk Reduction [inbe]
P NOS [aapp, imft]
Log [inpr]
Rank [inpr]
Test [lbpr]
treatment [ftcn]
Patients [podg]
picotamide [orch, phsu]
suffered [mobd]
Minor [popg]
Events [evnt]
Take [hlca]
placebo [topp]
suffered [mobd]
Minor [popg]
Events [evnt]
Sum [qnco]
Minor [popg]
Events [evnt]
picotamide [orch, phsu]
Group [idcn]
placebo [topp]
Group [idcn]
Risk Reduction [inbe]
P NOS [aapp, imft]
Log [inpr]
Rank [inpr]
Test [lbpr]
Conclusions [idcn]
Study [mnob]
picotamide [orch, phsu]
cardiovascular complications [patf]
Peripheral vascular disease [dsyn]
Patients [podg]
Drug [phsu]
Reducing [qlco]
Events [evnt]
Suggest [idcn]
Make [ftcn]
picotamide [orch, phsu]
Peripheral vascular disease [dsyn]
Patients [podg]
High Risk [qlco]
cardiovascular complications [patf]
Efficacy [qlco]
